Glaukos (GKOS) R&D In Process (2017 - 2022)

Glaukos (GKOS) has 4 years of R&D In Process data on file, last reported at $10.0 million in Q2 2022.

• Quarterly R&D In Process rose 100.0% year-over-year to $10.0 million in Q2 2022, while the trailing twelve-month figure through Dec 2022 was $15.0 million (up 50.0% YoY) and the FY2022 annual result came in at $10.0 million, changed 0.0% from the prior year.
• R&D In Process rose to $10.0 million in Q2 2022 per GKOS's latest filing, from $5.0 million in the prior quarter.
• Across five years, R&D In Process topped out at $10.0 million in Q2 2022 and bottomed at $1.5 million in Q3 2019.
• The 3-year median for R&D In Process is $5.0 million (2021), against an average of $4.7 million.
• Peak annual rise in R&D In Process reached 100.0% in 2022, while the deepest fall reached 100.0% in 2022.
• Tracing GKOS's R&D In Process over 3 years: stood at $1.5 million in 2019, then soared by 233.33% to $5.0 million in 2021, then surged by 100.0% to $10.0 million in 2022.
• Per Business Quant, the three latest GKOS R&D In Process figures stand at $10.0 million (Q2 2022), $5.0 million (Q3 2021), and $5.0 million (Q2 2021).

Peer Comparison